Industry Leading Journal Neonatology Features Boppli® Pivotal Clinical Study

PyrAmes published Accuracy and Safety of a Continuous Noninvasive Blood Pressure Monitor in Neonates in Neonatology, a leading publication for fetal and neonatal research. The paper describes PyrAmes’ successful pivotal clinical study for Boppli®, its groundbreaking blood pressure monitoring solution for infants under critical care. The study, at five hospitals in the U.S. and Canada, compared Boppli’s blood pressure readings to those from arterial lines. The study found Boppli to be a promising alternative to cumbersome cuffs (providing only spot measurements) or invasive arterial lines for continuous noninvasive BP monitoring in infants, offering good accuracy and usability. Boppli does not require calibration. Study results were submitted to the FDA, resulting in 510(K) clearance.